SCHEDULE 13G/A: Harraden Circle Entities Divest Entire Stake in Psyence Biomedical Ltd., Marking Exit as Significant Shareholder
Beneficial Ownership Amendment
Harraden Circle Investments and its affiliated entities have filed an amendment to their Schedule 13G, reporting that they no longer beneficially own more than five percent of Psyence Biomedical Ltd.'s Class A Common Stock.
Summary
- Harraden Circle Investments, LLC, Harraden Circle Investors GP, LP, Harraden Circle Investors GP, LLC, Harraden Circle Investors, LP, Harraden Circle Special Opportunities, LP, and Frederick V. Fortmiller, Jr. (collectively, the "Reporting Persons") have filed an Amendment No. 6 to their Schedule 13G.
- The filing indicates that the Reporting Persons have ceased to be beneficial owners of more than five percent of the outstanding Class A Common Stock of Psyence Biomedical Ltd.
- As of the filing date, the aggregate amount beneficially owned by each Reporting Person is 0.00 shares, representing 0% of the class.
- This amendment serves as an exit filing for the Reporting Persons, signifying their complete divestment of a significant stake in the issuer.
- The shares were not acquired or held for the purpose of changing or influencing the control of Psyence Biomedical Ltd.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of a change in beneficial ownership, specifically an exit filing, without explicit positive or negative framing from the issuer or the reporting persons regarding the company's performance or outlook.
Future Outlook
No forward-looking statements or guidance were provided by Psyence Biomedical Ltd. in this filing, as it is a disclosure from a former significant shareholder.
Industry Context
This filing is a standard disclosure of a change in beneficial ownership by an institutional investor, indicating a divestment from a publicly traded company in the biomedical sector. It does not provide broader industry trends or competitive analysis.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which required the filing of this statement (Reporting Persons ceased to be beneficial owners of more than five percent). |
| 05/15/2025 | Date of filing of the Schedule 13G Amendment No. 6. |
Keywords
Psyence Biomedical Ltd., Schedule 13G, beneficial ownership, Harraden Circle Investments, Class A Common Stock, SEC filing, divestment, exit filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.